Triomics taps LLMs to accelerate cancer care, raises $15M
Estimated reading time: 1 minutes
In tests, Triomics’ OncoLLM outperformed larger open-source and proprietary LLMs at patient-trial matching and rivaled qualified medical experts and GPT-4.Read More
About The Author
Discover more from Artificial Race!
Subscribe to get the latest posts sent to your email.
